(3) In accordance with Article 5(3) of Regulation (EC) No 178/2002 of the European Parliament and of the Council , where international standards exist or their completion is imminent, they are to be taken into consideration in the development or adaptation of food law, except where such standards or relevant parts would be an ineffective or inappropriate means for the fulfilment of the legitimate objectives of food law or where there is a scientific justification, or where they would result in a different level of protection from the one determined as appropriate in the Union. Moreover, in accordance with Article 13, point (e), of that Regulation, the Union is to promote consistency between international technical standards and food law while ensuring that the high level of protection adopted in the Union is not reduced.

(4) The European Food Safety Authority (‘the Authority’) assessed the risks to consumers and produced a scientific report . In cases where the Authority had identified a potential consumer health risk, the Union presented reservations , to the Codex Committee on Pesticides Residues on the CXLs proposed. This was the case for the following pesticide/product combinations: acetamiprid (all products), chlorothalonil (all products), clofentezine (all products), clothianidin (all products), difenoconazole (all products), ethiprole (all products), fenpyroximate (lemons and lime, pummelo and grapefruits), fluensulfone (all products), imazalil (all products), isoprothiolane (all products), metconazole (all products), methoprene (all products), prothioconazole (all products), pydiflumetofen (all products), pyrasulfotole (all products), pyraziflumid (all products), quinoxyfen (all products), spinetoram (tea, green, black), spiropidion (all products), tebuconazole (all products), thiamethoxam (all products), trifloxystrobin (all products), and trinexapac-ethyl (all products).

(5) Those CXLs for which the Union did not present a reservation to the Codex Committee on Pesticides Residues since the Authority did not identify risks for consumers in the Union, can therefore be considered safe. This is the case for certain CXLs for bixafen, cyprodinil, fenhexamid, fenpicoxamid, fenpyroximate, flutianil, isoxaflutole, mandipropamid, methoxyfenozide and spinetoram. Those CXLs should therefore be included in Regulation (EC) No 396/2005, except where they relate to products which are not listed in Annex I to that Regulation or where they are at a lower level than the current MRLs. Thus, no change should be made as regards the MRLs for fluopyram.

(6) Based on the scientific report of the Authority and taking into account the relevant factors listed in Article 14(2) of Regulation (EC) No 396/2005, the appropriate modifications to the MRLs fulfil the requirements of that article.

(7) Regulation (EC) No 396/2005 should therefore be amended accordingly.

(8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,